Myriad Genetics Ownership | Who Owns Myriad Genetics?


OverviewForecastRevenueFinancialsChartTranscripts

Myriad Genetics Ownership Summary


Myriad Genetics is owned by 97.65% institutional investors, 2.74% insiders. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.94% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMyriad Genetics97.65%2.74%-0.39%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryDiagnostics & Research Stocks57.60%10.69%31.72%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock15.15M18.54%$370.59M
Blackrock funding, inc. /de15.07M16.29%$80.03M
Vanguard group10.59M11.65%$145.20M
State street4.34M5.31%$106.25M
Glenview capital management4.59M4.96%$24.36M
Millennium management4.35M4.78%$59.57M
Bank of america corp /de/2.71M3.31%$66.18M
Dimensional fund advisors lp2.27M2.50%$31.15M
Geode capital management2.14M2.36%$29.39M
Qube research2.05M2.22%$10.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Amh equity300.00K2.09%$1.59M
Anson funds management lp1.35M1.03%$7.15M
Camber capital management lp2.00M1.00%$10.62M
Glenview capital management4.59M0.68%$24.36M
Knott david m jr180.00K0.43%$955.80K
Portolan capital management1.16M0.39%$6.18M
Aimz investment advisors39.19K0.19%$537.23K
Entrypoint capital38.63K0.10%$205.15K
Disciplined growth investors inc /mn753.96K0.08%$4.00M
Oxford asset management llp33.96K0.07%$180.35K

Top Buyers

HolderShares% AssetsChange
Anson funds management lp1.35M1.03%1.35M
Acadian asset management969.13K0.01%969.13K
Glenview capital management4.59M0.68%687.86K
D. e. shaw1.82M0.02%668.43K
Qube research2.05M0.01%633.44K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp---4.59M
Disciplined growth investors inc /mn753.96K0.08%-3.98M
Earnest partners---3.98M
Sei investments---2.42M
Artisan partners limited partnership---2.28M

New Positions

HolderShares% AssetsChangeValue
Anson funds management lp1.35M1.03%1.35M$7.15M
Acadian asset management969.13K0.01%969.13K$5.14M
Susquehanna portfolio strategies456.14K0.05%456.14K$2.42M
Canada pension plan investment board308.10K0.00%308.10K$1.64M
Amh equity300.00K2.09%300.00K$1.59M

Sold Out

HolderChange
Sjs investment consulting-2.00
Mendota financial group-3.00
Jfs wealth advisors-3.00
Global financial private client-3.00
Mather group, llc.-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025218-5.63%90,330,011-3.80%970.92%1308.33%52-32.47%
Mar 31, 20252303.60%93,858,1281.60%1031.00%119-1.65%774.05%
Dec 31, 2024205-17.00%86,534,887-4.62%950.77%111-15.91%70-1.41%
Sep 30, 20242457.46%90,699,410-1.73%1100.87%1313.15%7112.70%
Jun 30, 202422820.00%92,294,010-1.65%1120.86%12738.04%63-1.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.53M5.94%988.00
Vanguard Explorer Inv3.10M3.40%-190.91K
Vanguard US Total Market Shares ETF2.70M2.96%2.75K
Vanguard Total Stock Mkt Idx Inv2.66M2.85%-58.92K
iShares Russell 2000 ETF2.14M2.30%-40.74K
Artisan Non-U.S. Small-Mid Growth Comp1.56M1.70%-281.57K
Artisan International Small-Mid Investor1.56M1.70%-281.57K
EARNEST Partners Smid Cap Core Founders1.40M1.52%-970.66K
SPDR® S&P Biotech ETF1.37M1.48%33.83K
Vanguard Small Cap Index1.06M1.14%-7.19K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 11, 2024DIAZ PAUL J President and CEOSell$343.95K
Sep 11, 2024DIAZ PAUL J President and CEOSell$400.80K
Sep 11, 2024Muzzey Dale Chief Scientific OfficerSell$54.96K
Sep 09, 2024Dreismann Heinrich-Sell$270.52K
Sep 03, 2024Reitan Colleen F-Sell$1.29M

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4-1
2024 Q3-6

MYGN Ownership FAQ


Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 97.65%, followed by 2.74% insiders and -0.39% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 57.60%, which Myriad Genetics exceeds.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Blackrock (15.15M shares, 18.54%), Blackrock funding, inc. /de (15.07M shares, 16.29%), and Vanguard group (10.59M shares, 11.65%). Together, they hold 46.48% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Amh equity is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 2.09% of its assets in 300K Myriad Genetics shares, valued at 1.59M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 5.94% of its total shares outstanding invested in 5.53M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools